All Type of News
GP Pharm to revive Lee Myung-rae plasterGP Pharm announced recently it will re-launch Lee-Myung-rae sticking plaster, an old-fashioned adhesive bandage for healing abscess, from next month.
Launched in 1906, Lee My...
|
KPMA to oppose against big FTA deals on drug issues.
The 8th KORUS FTA meeting was scheduled to hold on March 6, and the KPMA top executive groups met with the chief negotiators of the Ministry of Foreign Affairs and Trade, delivering the KPMA official position that any...
Drug wholesalers vow to resist Zuellig's tighter margin policy
The majority of associate drug wholesalers for Zuellig Korea will roll their sleeves to thwart Zuellig's attempt to reduce further wholesaler margin, as Zuellig and associate wholesalers are expected to renew their ag...
KFTA, industry to launch administrative reform team
Representatives from the Korea Food and Drug Administration a variety of pharmaceutical organizations will form a new working-level committee to overhaul the existing drug-related rules, improve administrative process...
Government and civic group to induce foreigner patients.
An international medical service organization called "Korea International Medical Service Council" comprising of the government and civic cooperative groups was established on March 5 at Seoul Education Culture Center...
New GMP-accredited mark for health foods proposed
The Korea Food and Drug Administration on March 7 proposed a new scheme to allow GMP-endorsed health food makers to attach GMP certification phrase or its related mark.
Under the new plan, GMP-accredited health foo...
Imported finished drugs soaring up.
The total 2,213 finished drugs were imported last year including Novartis' Gleevec, the top imported drug along with Avandia and Diovan.
The Korea Pharmaceutical Traders Association reported the import status of 20...
Pfizer Korea outshine GSK in 2006 sales
Pfizer Korea has regained momentum in last year's sales and reaffirmed its industry leadership over GlaxoSmithKline and Sanofi-Aventis Korea.
The sales gap among three foreign-invested pharmaceutical firms is expec...
Local companies to change names for R&D centered enterprise.
Many local drug companies have changed their names in an attempt to transform their company images as an R&D centered company especially amid unclear external business environmental challenges arising from the KORUS F...
Dong-A's Bacchus grabs bigger market share in PhilippinesDong-A Pharmaceutical, the nation's largest drugmaker, is expanding its share of Bacchus, Korea's No. 1 tonic drink, in Philippines dominated by international makers.
Dong-A ...
|
